Time to benefit of incretin-based therapies in adiposity-related heart failure with mildly reduced or preserved ejection fraction: a systematic review and meta-analysis
Listen to this summary
The authors aimed to determine the time to clinical benefit of incretin-based therapies in patients with adiposity-related heart failure with mildly reduced or preserved ejection fraction. Their systematic review and meta-analysis of four randomized controlled trials revealed that these therapies significantly reduced worsening heart failure events, with sustained benefits observed starting around six months after treatment initiation.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.
More from Journal of cardiac failure
View all →Jul 11, 2026 · Journal of cardiac failure
An abbreviated exercise right heart catheterization protocol for the diagnosis of heart failure with preserved ejection fraction
Jul 10, 2026 · Journal of cardiac failure
SLEEP-DISORDERED BREATHING IN HEART FAILURE: PHENOTYPES, MECHANISMS, AND PRECISION APPROACH
Jul 4, 2026 · Journal of cardiac failure
Heart Failure Pharmacotherapy Across the TAVR Continuum
Jun 29, 2026 · Journal of cardiac failure
Predictors and Outcomes of Heart Failure Diagnosis in the Community When Compared to Acute Care Settings: Insights from Linked Administrative Health Databases
Jun 11, 2026 · Journal of cardiac failure
Automated SCAI staging as a novel decision aid in cardiogenic shock management
Jun 11, 2026 · Journal of cardiac failure
A Novel Model to Predict Progression to Death After Withdrawal of Care in Potential Donation-After-Circulatory-Death Heart Donors
More in Internal Medicine
View all →Jul 12, 2026 · JAMA
YEARS Algorithm for Diagnosis of Suspected Pulmonary Embolism in Patients With Cancer: A Randomized Clinical Trial
Jul 11, 2026 · American heart journal
Antegrade dissection and re-entry versus retrograde strategy in chronic total occlusion percutaneous coronary intervention: Rationale and design of the ADRENALINE randomized study
Jul 11, 2026 · Mayo Clinic proceedings
Embedding Ethics Into Decision-Making Capacity Assessment:An EHR-Enabled Systemwide Approach
Jul 11, 2026 · American heart journal
Integrative assessment of high-sensitivity C-reactive protein and lipid levels in predicting 20-year atherosclerotic cardiovascular disease risk, in a Mediterranean population: The ATTICA study (2002-2022)
Jul 11, 2026 · American heart journal
Interpreting apparent differences among the major colchicine trials for cardiovascular prevention: a descriptive compatibility analysis
Jul 11, 2026 · Journal of addiction medicine
Multiple Substance Use Disorders From Adolescence to Midlife
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR
Stay current without falling behind
33,000+ journals. 3-minute audio summaries. Free for 14 days.
